liveattenu
measl
viru
mv
vaccin
base
strain
play
signific
role
control
measl
china
howev
consider
advers
effect
may
caus
public
health
burden
hypothes
safeti
efficaci
mv
vaccin
improv
alter
sadenosylmethionin
sam
bind
site
conserv
region
vi
larg
polymeras
protein
test
hypothesi
establish
effici
revers
genet
system
strain
gener
two
recombin
carri
mutat
sam
bind
site
two
mutant
grew
high
titer
vero
cell
genet
stabl
significantli
attenu
vitro
vivo
compar
parent
vaccin
strain
importantli
mutant
trigger
higher
neutral
antibodi
vaccin
provid
complet
protect
mv
challeng
result
demonstr
potenti
improv
mv
vaccin
candid
measl
viru
mv
envelop
viru
nonseg
negativesens
nn
rna
genom
famili
paramyxovirida
order
mononegaviral
develop
countri
measl
still
lead
caus
mortal
children
griffin
oldston
tangi
naim
though
vaccin
effect
econom
safe
way
prevent
outbreak
bester
de
vri
et
al
earli
liveattenu
vaccin
base
strain
mv
develop
current
wide
use
immun
provinc
china
zhang
et
al
vaccin
efficaci
associ
advers
effect
mani
vaccin
infant
children
china
experienc
side
effect
rang
skin
rash
itch
swell
high
fever
bester
shu
et
al
addit
outbreak
measl
increas
significantli
past
year
china
particularli
increas
proport
adult
infant
case
et
al
zhang
et
al
infect
adult
receiv
measl
vaccin
childhood
still
remain
suscept
infect
measl
viru
popul
immun
measl
vaccin
gradual
reduc
time
abad
safdar
gao
et
al
et
al
zhang
et
al
thu
increas
urgenc
develop
safer
effici
mv
vaccin
erad
measl
china
revers
genet
system
establish
mani
nn
rna
virus
includ
vesiculoviru
morbilliviru
respiroviru
pneumoviru
neumann
et
al
similar
nn
rna
virus
minim
machineri
mv
transcript
replic
ribonucleoprotein
rnp
complex
consist
nucleocapsid
n
rna
templat
tightli
associ
rnadepend
rna
polymeras
larg
l
protein
phosphoprotein
p
assembl
replicationcompet
rnp
essenti
rescu
nn
rna
virus
bukreyev
et
al
clark
et
al
garcin
et
al
gassen
et
al
jin
et
al
lawson
et
al
achiev
cotransfect
plasmid
encod
fulllength
antigenom
cdna
togeth
plasmid
encod
n
p
l
gene
previous
sever
group
alreadi
success
rescu
infecti
mv
cdna
clone
duprex
et
al
kovac
et
al
nakatsu
et
al
park
et
al
radeck
et
al
sidhu
et
al
revers
genet
system
facilit
ration
design
safer
effici
measl
vaccin
candid
l
protein
nn
rna
virus
possess
major
enzymat
activ
transcript
replic
ferron
et
al
poch
et
al
whelan
et
al
transcript
nn
rna
virus
synthes
mrna
cap
methyl
polyadenyl
end
recent
studi
shown
entir
mrna
cap
methyl
machineri
nn
rna
virus
distinct
host
ferron
et
al
furuichi
shatkin
ogino
banerje
zhang
et
al
use
vesicular
stomat
viru
vsv
model
found
vsv
mrna
cap
catalyz
rna
gdp
polyribonucleotidyltransferas
prntase
l
protein
transfer
monophosph
rna
onto
gdp
acceptor
li
et
al
ogino
banerje
mrna
cap
methyl
nn
rna
virus
also
unusu
singl
region
l
protein
catalyz
ribos
methyl
li
et
al
rahmeh
et
al
thu
mrna
cap
format
excel
target
develop
antivir
drug
live
vaccin
candid
nn
rna
virus
base
sequenc
align
l
protein
contain
six
conserv
region
cr
number
vi
recent
studi
show
cr
v
l
protein
possess
mrna
cap
enzym
wherea
cr
vi
respons
mrna
cap
methyltransferas
mtase
activ
li
et
al
ogino
et
al
shown
mutat
cap
enzym
lethal
viru
howev
mutat
mtase
region
yield
recombin
virus
attenu
vitro
vivo
suggest
mrna
cap
mtase
novel
target
ration
design
live
attenu
vaccin
nn
rna
virus
novel
concept
recent
test
sever
nn
rna
virus
includ
vsv
avian
metapneumoviru
ampv
human
metapneumoviru
hmpv
rabi
viru
rabv
li
et
al
sun
et
al
tian
et
al
zhang
et
al
shown
recombin
virus
lack
mtase
activ
highli
attenu
vitro
vivo
yet
retain
optim
immunogen
hypothes
engin
mutat
mtase
region
mv
l
protein
would
lead
attenu
current
live
attenu
vaccin
strain
enhanc
safeti
mv
vaccin
test
hypothesi
establish
robust
revers
genet
system
base
chines
mv
vaccin
strain
allow
us
recov
recombin
mv
bhk
cell
stabli
express
rna
polymeras
xu
et
al
zhang
et
al
subsequ
two
recombin
mv
amino
acid
aa
substitut
sadenosylmethionin
sam
bind
site
l
protein
success
recov
two
mtasedefect
mutant
delay
replic
kinet
grew
high
titer
genet
stabl
passag
cell
cultur
mv
mutant
significantli
attenu
vitro
vivo
compar
parent
vaccin
strain
interestingli
mutant
induc
significantli
higher
neutral
antibodi
titer
compar
parent
fig
construct
fulllength
cdna
clone
promot
noncod
termini
nct
antigenom
hdv
ribozym
termin
assembl
sever
round
fusion
pcr
insert
use
seamless
clone
strategi
result
construct
eight
overlap
fragment
contain
fulllength
mv
genom
assembl
creat
pyesmv
b
spontan
mutat
c
u
h
gene
distinguish
labpropag
parent
viru
rescu
recombin
viru
mark
b
viru
result
demonstr
alter
sam
bind
site
mv
l
protein
enhanc
safeti
profil
immunogen
mv
vaccin
thu
mrna
cap
mtase
serv
novel
approach
ration
design
safer
efficaci
mv
vaccin
fulllength
cdna
clone
mv
strain
pyesmv
construct
novel
methodolog
use
highord
genet
assembl
system
fulllength
cdna
clone
success
assembl
singl
step
ligat
without
need
restrict
endonucleas
antigenom
mv
cdna
clone
control
rna
polymeras
promot
hepat
delta
viru
hdv
ribozym
sequenc
termin
fig
tabl
recov
infecti
mv
cell
stabli
express
rna
polymeras
cotransfect
fulllength
cdna
clone
pyesmv
support
plasmid
express
ribonucleoprotein
three
day
posttransfect
cell
monolay
trypsin
cocultur
fresh
vero
cell
mvinduc
syncytia
observ
day
later
fig
b
c
success
recoveri
confirm
detect
n
protein
express
vero
cell
infect
rescu
immunofluoresc
assay
fig
extens
syncytia
observ
cell
harvest
supernat
use
passag
vero
cell
passag
recombin
mv
plaqu
purifi
larg
stock
viru
prepar
spontan
mutat
c
u
nucleotid
nt
posit
within
h
gene
labpropag
parent
viru
differ
publish
sequenc
genbank
access
site
pyesmv
mutat
back
c
sitedirect
mutagenesi
pcr
distinguish
parent
viru
lab
ident
publish
sequenc
confirm
recov
recombin
viru
origin
pyesmv
crosscontamin
parent
grown
laboratori
region
rmv
h
gene
amplifi
rtpcr
sequenc
result
show
contain
c
mutat
establish
robust
revers
genet
next
test
hypothesi
vaccin
strain
attenu
alter
sam
bind
site
mv
l
protein
previous
strategi
use
ration
design
live
attenu
vaccin
candid
vsv
ampv
hmpv
li
et
al
sun
et
al
zhang
et
al
samdepend
mtase
superfamili
typic
contain
conserv
grich
motif
bind
sam
molecul
methyl
donor
rna
methyl
mcilhatton
et
al
schluckebi
et
al
sequenc
align
reveal
gxgxgx
motif
conserv
cr
vi
l
protein
paramyxovirus
mononegaviral
fig
li
et
al
mcilhatton
et
al
poch
et
al
zhang
et
al
sequenc
analysi
found
aa
residu
correspond
gxgxgx
motif
mv
l
protein
includ
therefor
amino
acid
individu
mutat
alanin
infecti
cdna
clone
mv
pyesmv
three
recombin
mv
clone
singl
point
mutat
sam
bind
site
construct
use
revers
genet
system
two
recombin
mv
success
rescu
viral
titer
gradual
increas
passag
vero
cell
rmv
mutant
confirm
detect
n
protein
express
vero
cell
infect
rescu
rmv
mutant
immunofluoresc
fig
mutant
viabl
grew
poorli
vero
cell
passag
mutant
increas
viral
titer
data
shown
next
plaqu
purifi
size
virusinduc
plaqu
differ
rescu
parent
mutant
virus
demonstr
fig
day
incub
parent
form
plaqu
mm
diamet
wherea
averag
plaqu
significantli
smaller
mm
mm
respect
p
suggest
two
mv
mutant
like
impair
growth
kinet
caus
plaqu
size
reduc
final
entir
genom
mv
mutant
amplifi
rtpcr
sequenc
result
show
mutant
retain
desir
mutat
addit
mutat
found
genom
next
compar
replic
kinet
mutant
parent
viru
vero
cell
time
cours
h
infect
fig
parent
reach
peak
titer
log
pfuml
h
postinocul
hpi
peak
titer
two
mutant
hpi
importantli
delay
replic
reach
peak
titer
log
pfuml
hpi
compar
parent
viru
p
peak
titer
achiev
log
pfuml
hpi
significantli
lower
parent
hpi
p
mv
mutant
delay
cytopath
effect
cpe
compar
parent
viru
parent
develop
extens
celltocel
fusion
larg
syncytia
hpi
reach
maximum
cpe
hpi
wherea
mutant
delay
format
syncytia
reach
maximum
cpe
hpi
fig
data
suggest
rmv
carri
mutat
sam
bind
site
attenu
vero
cell
parent
mv
vaccin
strain
investig
whether
genet
stabl
vitro
viru
passag
vero
cell
time
mutat
region
l
gene
sequenc
first
passag
viru
passag
retain
desir
mutat
passag
entir
genom
mutant
sequenc
show
addit
mutat
genom
tabl
sequenc
oligonucleotid
use
pcr
sequenc
virolog
carri
mutat
sam
bind
site
attenu
vivo
parent
vaccin
strain
fourtosixweekold
specificpathogenfre
spf
cotton
rat
inocul
intranas
parent
mutant
order
determin
replic
vivo
clinic
symptom
respiratori
tract
infect
found
cotton
rat
inocul
rmv
day
postinocul
cotton
rat
termin
viral
titer
lung
determin
tabl
parent
viru
replic
effici
lung
averag
titer
log
pfug
lung
tissu
recombin
averag
titer
log
pfug
lung
tissu
signific
lower
p
howev
attenu
mutant
cotton
rat
detect
viral
titer
lung
titer
log
pfug
result
show
two
mutant
rmv
attenu
viral
replic
vivo
compar
parent
vaccin
strain
ensur
mutant
stabl
vivo
total
rna
extract
lung
sampl
region
harbor
mutat
amplifi
rtpcr
sampl
anim
sequenc
respect
result
show
desir
mutat
retain
anim
addit
mutat
detect
sequenc
region
mutant
induc
higher
neutral
antibodi
parent
vaccin
strain
provid
complet
protect
mv
challeng
immunogen
mutant
assess
cotton
rat
briefli
spf
cotton
rat
intranas
inocul
pfu
mv
challeng
pfu
week
postimmun
two
mutant
rmv
induc
high
level
neutral
antibodi
earli
week
vaccin
antibodi
gradual
increas
week
howev
antibodi
produc
parent
peak
week
declin
week
overal
antibodi
induc
compar
gener
wildtyp
week
p
fig
howev
week
neutral
antibodi
induc
mutant
significantli
higher
parent
p
fig
suggest
mutant
immunogen
compar
parent
vaccin
strain
week
postvaccin
cotton
rat
challeng
pfu
cotton
rat
termin
day
postchalleng
infecti
viru
detect
lung
tissu
vaccin
cotton
rat
tabl
contrast
averag
titer
log
pfug
detect
lung
tissu
unvaccin
challeng
control
result
show
provid
complet
protect
mv
challeng
studi
success
gener
two
recombin
measl
virus
amino
acid
substitut
sam
bind
site
l
protein
examin
effect
mutat
viral
replic
safeti
immunogen
found
significantli
attenu
compar
parent
wide
use
vaccin
china
rmv
carri
mutat
sam
bind
site
genet
stabl
form
significantli
smaller
viral
plaqu
delay
cpe
replic
kinet
recombin
grew
high
titer
vero
cell
compar
exhibit
significantli
attenu
cotton
rat
recombin
grew
rel
lower
titer
vero
cell
greater
degre
attenu
cotton
rat
compar
recombin
virus
trigger
significantli
higher
neutral
antibodi
compar
provid
complet
protect
mv
challeng
indic
alter
sam
bind
site
mv
l
protein
enhanc
safeti
immunogen
vaccin
strain
establish
effici
method
assembl
fulllength
cdna
clone
without
use
restrict
endonucleas
mv
genom
divid
eight
overlap
fragment
assembl
fulllength
plasmid
use
highord
genet
assembl
system
tradit
method
assembl
infecti
cdna
requir
multipl
clone
step
involv
restrict
enzym
digest
ligat
time
consum
labor
extens
technic
challeng
tradit
clone
strategi
also
often
lead
unexpect
delet
insert
mutat
viral
genom
hamper
subsequ
viru
rescu
assembl
strategi
highli
effici
allow
us
obtain
fulllength
cdna
clone
singl
step
previous
vaccinia
viru
provid
rna
polymeras
often
use
rescu
mv
revers
genet
system
howev
difficulti
separ
rescu
mv
helper
virus
bhk
cell
stabli
express
rna
polymeras
instead
use
rescu
hmpv
bovin
respiratori
syncyti
viru
buchholz
et
al
zhang
et
al
studi
cell
cotransfect
plasmid
express
antigenom
mv
cdna
support
plasmid
express
mv
n
p
l
protein
allow
effici
recoveri
infecti
mv
vaccinia
virusfre
cell
system
primari
advantag
system
elimin
potenti
contamin
vaccinia
viru
rescu
system
highli
effici
abl
recov
mani
mutant
cr
vi
l
protein
includ
two
recombin
virus
aa
substitut
sam
bind
site
report
studi
live
attenu
vaccin
promis
vaccin
human
paramyxovirus
caus
enhanc
lung
diseas
upon
reinfect
viru
liveattenu
vaccin
base
strain
mv
develop
wide
use
immun
chines
infant
children
zhang
et
al
howev
epidemiolog
studi
show
vaccin
still
caus
advers
effect
may
caus
public
health
burden
addit
safeti
issu
measl
outbreak
increas
recent
year
like
due
gradual
reduc
popul
immun
measl
vaccin
time
abad
safdar
gao
et
al
et
al
zhang
et
al
studi
sought
improv
safeti
efficaci
current
mv
vaccin
mutat
sam
bind
site
l
protein
use
robust
revers
genet
carri
mutat
sam
bind
site
success
rescu
mutant
produc
smaller
plaqu
delay
growth
kinet
delay
syncytia
format
compar
parent
clearli
mutant
significantli
attenu
vero
cell
parent
cotton
rat
significantli
lower
viral
titer
lung
p
recombin
even
attenu
inocul
cotton
rat
detect
viral
titer
lung
despit
high
attenu
phenotyp
grew
high
titer
compar
parent
vaccin
viru
vero
cell
approv
cell
line
vaccin
product
although
grew
slightli
lower
titer
log
less
vero
cell
still
econom
feasibl
vaccin
product
anoth
advantag
use
greater
degre
attenu
vitro
vivo
compar
interestingli
mutant
trigger
higher
level
neutral
antibodi
parent
suggest
greater
immunogen
final
cotton
rat
vaccin
mutant
complet
protect
mv
challeng
thu
recombin
carri
mutat
sam
bind
site
potenti
improv
vaccin
candid
mv
novel
find
recombin
carri
mutat
sam
bind
site
trigger
higher
neutral
antibodi
compar
parent
strain
although
detail
mechan
explor
studi
possibl
mv
mutant
may
trigger
higher
innat
immun
turn
trigger
robust
adapt
immun
fact
shown
coronaviru
lack
methyl
significantli
enhanc
type
interferon
respons
anoth
advantag
use
viral
mrna
cap
mtase
target
develop
live
vaccin
candid
previous
found
two
pneumovirus
ampv
hmpv
carri
mutat
sam
bind
site
cr
vi
l
protein
specif
defect
ribos
methyl
methyl
significantli
attenu
retain
wildtyp
level
immunogen
addit
found
mtasedefect
hmpv
highli
sensit
treatment
sun
et
al
zhang
et
al
given
fact
mtase
domain
highli
conserv
l
protein
nn
rna
virus
gener
mechan
attenu
virus
lack
methyl
may
similarli
conserv
nn
rna
virus
futur
experi
investig
mechan
mv
mutant
enhanc
immunogen
establish
novel
effici
strategi
assembl
fulllength
cdna
clone
establish
effici
vaccinia
virusfre
revers
genet
system
gener
two
recombin
carri
mutat
sam
bind
site
grew
high
titer
vero
cell
genet
stabl
also
significantli
attenu
immunogen
compar
current
use
chines
mv
vaccin
strain
two
recombin
virus
may
serv
improv
vaccin
candid
mv
vero
cell
african
green
monkey
cell
kindli
offer
apath
llc
brooklyn
ny
grown
dulbecco
modifi
eagl
medium
dmem
life
technolog
supplement
fetal
bovin
serum
fb
chines
vaccin
strain
mv
obtain
dr
yiyu
lu
zhejiang
cdc
passag
vero
cell
viral
rna
extract
use
rneasi
minikit
qiagen
reversetranscrib
use
super
iii
revers
transcriptas
invitrogen
random
primer
mix
neb
genom
amplifi
eight
overlap
fragment
highfidel
master
mix
neb
use
eight
pair
mvspecif
primer
tabl
clone
peasyblunt
vector
transgen
accord
manufactur
instruct
result
eight
plasmid
contain
fulllength
genom
peasyn
peasyp
peasyf
peasyh
sequenc
found
ident
publish
sequenc
genbank
access
except
singl
point
chang
c
u
nt
within
h
gene
mutat
peasyh
correct
sitedirect
mutagenesi
specif
primer
tabl
result
plasmid
name
peasyhm
sever
round
amplif
infus
pcr
use
assembl
five
fragment
promot
mv
noncod
termini
nct
nt
nt
respect
amplifi
peasyn
respect
hepat
delta
viru
hdv
ribozym
nt
antigenom
hdv
sequenc
termin
subsequ
insert
plasmid
use
seamless
clone
assembl
kit
invitrogen
fig
creat
plasmid
primer
sequenc
approach
use
pcr
assay
avail
upon
request
ten
fragment
success
assembl
fulllength
cdna
clone
use
highord
genet
assembl
system
accord
manufactur
manual
fig
creat
plasmid
pyesmv
eight
genom
fragment
amplifi
specif
primer
peasyn
peasyp
peasyf
peasyhm
insert
contain
promot
mv
nct
hdv
ribozym
termin
divid
two
fragment
pcr
amplif
specif
primer
r
backbon
vector
contain
rna
polymeras
promot
encephalomyocard
emc
viru
intern
ribosom
entri
site
ire
termin
sequenc
use
construct
plasmid
encod
n
p
l
gene
open
read
frame
orf
mv
n
p
gene
amplifi
peasyn
peasyp
use
primer
pair
mvcdsn
mvcdsp
respect
wherea
orf
mv
l
gene
amplifi
use
two
primer
pair
mv
n
p
l
gene
insert
vector
ire
polya
tabl
replic
mutant
cotton
rat
infect
anim
viral
titer
log
pfug
b
c
b
b
dmem
nd
nd
detect
cotton
rat
inocul
intranas
pfu
mutant
volum
day
postinfect
cotton
rat
sacrif
lung
collect
viru
titrat
rtpcr
b
viral
titer
determin
plaqu
assay
c
five
cotton
rat
test
group
valu
within
column
follow
differ
capit
letter
b
significantli
differ
fig
neutral
antibodi
titer
produc
cotton
rat
inocul
recombin
mv
cotton
rat
intranas
inocul
pfu
mutant
ml
optimem
medium
weekli
blood
sampl
collect
cotton
rat
facial
vein
retroorbit
bleed
serum
test
neutral
antibodi
plaquereduct
neutral
assay
b
recombin
mv
carri
mutat
sam
bind
site
elicit
significantli
higher
level
p
neutral
antibodi
week
postinocul
p
p
p
sequenc
use
seamless
clone
strategi
result
construct
respect
primer
sequenc
use
pcr
assay
avail
upon
request
recov
recombin
mv
cell
grown
overnight
sixwel
plate
approxim
confluenc
transfect
pyesmv
use
previous
describ
procedur
carsillo
et
al
kovac
et
al
singh
billet
h
posttransfect
cell
monolay
trypsin
directli
transfer
onto
vero
cell
monolay
confluenc
cocultur
day
cell
subject
three
freezethaw
cycl
extens
cpe
mvinduc
syncytia
observ
brief
centrifug
supernat
harvest
use
passag
confluent
vero
cell
monolay
recov
virus
plaqu
purifi
sequenc
vero
cell
grown
tissu
cultur
plate
infect
rmv
rmvmutant
h
incub
cell
wash
two
time
pb
cultiv
dmem
contain
fb
h
postinfect
cell
fix
paraformaldehyd
pb
min
rt
permeabil
triton
merck
millipor
pb
min
rt
block
bsa
pb
contain
tween
h
rt
cell
stain
mous
antimeasl
viru
n
antibodi
abcam
h
rt
wash
pb
alexa
fluor
donkey
antimous
igg
hl
invitrogen
ad
incub
h
rt
cell
stain
dapi
min
rt
imag
obtain
use
zeiss
confoc
laser
scan
microscop
zen
softwar
amino
acid
sam
bind
site
l
protein
mutat
alanin
individu
ggt
gct
aa
posi
tion
gga
gca
aa
posit
ggt
gct
aa
posit
mutat
nucleotid
underlin
infecti
cdna
clone
pyesmv
use
sitedirect
mutagenesi
kit
neb
accord
manufactur
instruct
result
plasmid
name
pyesmv
pyesmv
pyesmv
mutat
confirm
dna
sequenc
titer
virus
determin
plaqu
assay
vero
cell
briefli
vero
cell
seed
sixwel
plate
densiti
cell
per
well
incub
h
medium
remov
prior
infect
cell
monolay
serial
dilut
h
adsorpt
constant
shake
medium
remov
cell
monolay
cover
ml
eagl
minim
essenti
media
mem
contain
agaros
sodium
bicarbon
fb
nm
hepe
mm
lglutamin
mgml
streptomycin
dpi
cell
fix
volvol
paraformaldehyd
h
plaqu
visual
stain
wtvol
crystal
violet
confluent
vero
cell
sixwel
plate
infect
virus
multipl
infect
moi
h
incub
inoculum
remov
cell
wash
three
time
pb
fresh
mainten
media
dmem
supplement
fb
ad
infect
cell
incub
differ
time
point
postinfect
cell
harvest
three
freezethaw
cycl
supernat
collect
centrifug
allegra
centrifug
beckman
coulter
min
viru
titer
determin
plaqu
assay
vero
cell
confluent
vero
cell
flask
infect
mutant
moi
cell
cultur
supernat
collect
appear
cpe
use
infect
new
confluent
vero
cell
fresh
flask
mutant
serial
passag
time
vero
cell
viral
rna
extract
cell
cultur
supernat
harvest
passag
cr
vi
l
gene
amplifi
rtpcr
sequenc
addit
entir
genom
recombin
viru
amplifi
rtpcr
sequenc
passag
plasmid
viral
stock
viru
isol
lung
cotton
rat
sequenc
viral
rna
isol
use
rneasi
minikit
qiagen
accord
manufactur
instruct
viral
rna
treat
dnase
elimin
possibl
contamin
origin
transfect
plasmid
dna
nort
pcr
control
carri
confirm
complet
digest
plasmid
dna
kb
dna
fragment
h
protein
gene
amplifi
onestep
rtpcr
kit
qiagen
use
primer
pcr
product
sequenc
ensur
isol
viru
rescu
pyesmv
contamin
wild
type
grown
laboratori
kb
dna
fragment
span
cr
vi
mv
lprotein
amplifi
onestep
rtpcr
kit
qiagen
use
primer
pcr
product
sequenc
confirm
recombin
viru
contain
desir
mutat
stock
use
anim
experi
grown
vero
cell
purifi
ultracentrifug
twenti
flask
confluent
vero
cell
infect
rmv
moi
h
adsorpt
constant
shake
ml
dmem
supplement
fb
ad
flask
incub
extens
cpe
observ
cell
harvest
use
cellscrap
suspens
clarifi
centrifug
tabl
immunogen
mtasedefect
mutant
cotton
rat
inoculum
infect
anim
viral
titer
log
pfug
b
nd
nd
nd
dmem
nd
detect
cotton
rat
intranas
inocul
pfu
mutant
day
postinfect
rat
challeng
pfu
day
postchalleng
cotton
rat
sacrif
lung
collect
viru
titrat
rtpcr
b
viral
titer
determin
plaqu
assay
min
allegra
r
centrifug
beckman
coulter
cell
pellet
resuspend
ml
dmem
subject
three
freezethaw
cycl
clarifi
lowspe
centrifug
supernat
combin
viru
pellet
ultracentrifug
beckman
ty
rotor
h
resuspend
ml
dmem
aliquot
store
viral
titer
determin
plaqu
assay
twenti
weekold
femal
specificpathogenfre
spf
cotton
rat
envigo
indianapoli
randomli
divid
four
group
cotton
rat
per
group
hous
within
ular
facil
ohio
state
univers
accord
iacuc
polici
guidelin
anim
protocol
inocul
group
separ
hous
rodent
cage
biosafeti
level
condit
rat
anesthet
isofluran
viru
inocul
cotton
rat
group
inocul
parent
respect
cotton
rat
group
mockinfect
dmem
serv
uninfect
control
cotton
rat
inocul
intranas
pfu
viru
volum
dpi
cotton
rat
sacrif
lung
collect
viru
titrat
rtpcr
immunogen
studi
twenti
five
weekold
cotton
rat
envigo
randomli
divid
five
group
cotton
rat
per
group
cotton
rat
group
mockinfect
dmem
serv
uninfect
unchalleng
control
cotton
rat
group
intranas
inocul
pfu
respect
cotton
rat
group
mockinfect
dmem
serv
uninfect
challeng
control
immun
cotton
rat
evalu
daili
mortal
blood
sampl
collect
cotton
rat
weekli
facial
vein
retroorbit
bleed
serum
use
detect
neutral
antibodi
week
postimmun
cotton
rat
group
challeng
pfu
parent
via
intranas
rout
evalu
twice
daili
presenc
clinic
symptom
day
postchalleng
cotton
rat
euthan
co
asphyxi
lung
collect
viru
titrat
immunogen
mutant
assess
base
abil
trigger
neutral
antibodi
abil
protect
mv
replic
lung
serum
neutral
viru
perform
use
endpoint
dilut
plaqu
reduct
assay
ii
quantif
lung
viral
titer
done
plaqu
assay
mvspecif
neutral
antibodi
determin
use
endpoint
dilut
plaqu
reduct
assay
briefli
cotton
rat
sera
collect
weekli
challeng
serum
sampl
heat
inactiv
min
twofold
dilut
serum
sampl
mix
equal
volum
dmem
contain
approxim
pfuwel
plate
plate
incub
room
temperatur
h
constant
rotat
mixtur
transfer
confluent
vero
cell
plate
triplic
h
incub
virusserum
mixtur
remov
cell
monolay
cover
ml
eagl
minim
essenti
media
mem
contain
agaros
sodium
bicarbon
fb
nm
hepe
mm
lglutamin
mgml
streptomycin
cell
incub
anoth
day
viru
plaqu
titrat
describ
plaqu
count
plaqu
reduct
titer
calcul
mvspecif
neutral
antibodi
titer
statist
analysi
perform
oneway
multipl
comparison
twoway
multipl
comparison
anova
use
prism
statist
analysi
softwar
version
p
valu
consid
statist
signific
